DrugPatentWatch Database Preview

Details for Patent: 6,884,434

« Back to Dashboard

Which drugs does patent 6,884,434 protect, and when does it expire?

Patent 6,884,434 protects NEUPRO and is included in one NDA.

This patent has thirty-nine patent family members in thirty countries.

Summary for Patent: 6,884,434

Title:	Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
Abstract:	A transdermal therapeutic system, comprising a backing layer inert to the components of the matrix, a self-adhesive matrix layer containing (-)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]amino]-1-naphthalenol in an effective amount and a protective foil or sheet to be removed prior to use, is characterised by a matrix that is based on a non-aqueous, acrylate-based or silicone-based polymer adhesive system having a solubility of .gtoreq.5% (w/w) for (-)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]-amino]-1-naphthaleno l, and said matrix is substantially free of inorganic silicate particulates.
Inventor(s):	Muller; Walter (Neuwied, DE), Peck; James V. (Richmond, VA)
Assignee:	LTS Lohmann Therapie-Systeme AG (Andernach, DE) Aderis Pharmaceuticals, Inc. (Richmond, VA)
Application Number:	09/647,290
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,884,434
Patent Claim Types: see list of patent claims	Use; Compound;

Drugs Protected by US Patent 6,884,434

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Ucb Inc	NEUPRO	rotigotine	FILM, EXTENDED RELEASE;TRANSDERMAL	021829-004	Apr 2, 2012		RX	Yes	No			Y
Ucb Inc	NEUPRO	rotigotine	FILM, EXTENDED RELEASE;TRANSDERMAL	021829-001	May 9, 2007		RX	Yes	Yes			Y
Ucb Inc	NEUPRO	rotigotine	FILM, EXTENDED RELEASE;TRANSDERMAL	021829-005	Apr 2, 2012		RX	Yes	No			Y
Ucb Inc	NEUPRO	rotigotine	FILM, EXTENDED RELEASE;TRANSDERMAL	021829-002	May 9, 2007		RX	Yes	No			Y

Foreign Priority and PCT Information for Patent: 6,884,434

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	198 14 084	Mar 30, 1998

PCT Information
PCT Filed	March 18, 1999	PCT Application Number:	PCT/EP99/01795
PCT Publication Date:	October 07, 1999	PCT Publication Number:	WO99/49852

Non-Orange Book US Patents Family Members for Patent 6,884,434

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
7,413,747	Transdermal therapeutic system for treating Parkinsonism

International Family Members for US Patent 6,884,434

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	014778
Austria	210973
Australia	2934199
Australia	746856